RxDoctor Payments Data

Kyle Packer

Surgery · Jasper, ALNPI 1710228986

Payments from drug & device makers

$7,937in general payments, 2019–2025

Across 86 payments — averaging $92.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$2K
  • Enterra Medical, Inc.$2K
  • Boston Scientific$2K
  • Intuitive Surgical$1K
  • Smith+Nephew$418
  • Johnson & Johnson$120
  • plus $300 from 7 others

What the payments were for

  • Travel & lodging$3,60745%
  • Food & beverage$4,26954%
  • Gifts$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,937 in reported general payments places this provider in the 80th percentile of 382 surgery providers in Alabama.

See all surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$141,618
Medicare patients
297
Services billed
866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide81$51,732
SantylCollagenase Clostridium Hist.11$17,084
Pantoprazole Sodium304$2,051
Sucralfate69$1,530
CholestyramineCholestyramine (With Sugar)18$1,407
Balsalazide Disodium11$1,197
Esomeprazole Magnesium30$783
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen168$770
Linezolid14$665
Omeprazole36$664
Ondansetron OdtOndansetron31$509
Ondansetron Hcl42$356
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine13$346
Dicyclomine Hcl19$280
Calcitriol16$222

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$418$17,08411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 382 surgery providers in Alabama.

Other surgery in Jasper

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →